Literature DB >> 29883596

Karnofsky performance status before and after liver transplantation predicts graft and patient survival.

Paul J Thuluvath1, Avesh J Thuluvath2, Yulia Savva3.   

Abstract

BACKGROUND & AIMS: The Karnofsky performance status (KPS) has been used for almost 70 years for clinical assessment of patients. Our objective was to determine whether KPS is an independent predictor of post-liver transplant (LT) survival after adjusting for known confounders.
METHOD: Adult patients listed with the United Network for Organ Sharing (UNOS) from 2006 to 2016 were grouped into low (10-40%, n = 15,103), intermediate (50-70%, n = 22,183) and high (80-100%, n = 13,131) KPS groups based on KPS scores at the time of LT, after excluding those on ventilators or life support. We determined the trends in KPS before and after LT, and survival probabilities based on KPS.
RESULTS: There was a decline in KPS scores between listing and LT and there was significant improvement after LT. The graft and patient survival differences were significantly lower (p <0.0001) in those with low KPS. After adjusting for other confounders, the hazard ratios for graft failure were 1.17 (1.12-1.22, p <0.01) for the intermediate and 1.38 (1.31-1.46, p <0.01) for the low group. Similarly, hazard ratios for patient failure were 1.18 (1.13-1.24, p <0.01) for the intermediate and 1.43 (1.35-1.52, p <0.01) for the low group. Other independent negative predictors for graft and patient survival were older age, Black ethnicity, presence of hepatic encephalopathy and donor risk index. Those who did not show significant improvements in post-LT KPS scores had poorer outcomes in all three KPS groups, but it was most obvious in the low KPS group with one-year patient survival of 33%.
CONCLUSION: The KPS, before and after LT, is an independent predictor of graft and patient survival after adjusting for other important predictors of survival. LAY
SUMMARY: The overall health of liver transplant recipients could be assessed by a simple clinical assessment tool called the Karnofsky performance status, which assesses an individual's overall functional status on an 11-point scale, in increments of 10, where a score of 0 is considered dead and 100 is considered perfect health. In this study, using a large dataset, we show that the performance status before and after liver transplant is a predictor of survival. More importantly, those who have low performance status before transplant and do not show an improvement in performance status between 3-12 months after liver transplant have very poor survival.
Copyright © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Karnofsky Performance Status; Liver transplant; Post-liver transplant survival; UNOS

Mesh:

Year:  2018        PMID: 29883596     DOI: 10.1016/j.jhep.2018.05.025

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

1.  Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates.

Authors:  Emily R Perito; John Bucuvalas; Jennifer C Lai
Journal:  Am J Transplant       Date:  2018-12-31       Impact factor: 8.086

Review 2.  The Impact of Frailty, Sarcopenia, and Malnutrition on Liver Transplant Outcomes.

Authors:  Nikki Duong; Brett Sadowski; Amol S Rangnekar
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

3.  Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.

Authors:  Patrick McCabe; Artin Galoosian; Robert J Wong
Journal:  Dig Dis Sci       Date:  2019-10-22       Impact factor: 3.199

4.  Functional status-based risk-benefit analyses of high-KDPI kidney transplant versus dialysis.

Authors:  Kevin Bui; Vikram Kilambi; Sanjay Mehrotra
Journal:  Transpl Int       Date:  2019-07-31       Impact factor: 3.782

5.  Functional Status at Liver Transplant Waitlisting Correlates With Greater Odds of Encephalopathy, Ascites, and Spontaneous Bacterial Peritonitis.

Authors:  Patrick McCabe; Grishma Hirode; Robert Wong
Journal:  J Clin Exp Hepatol       Date:  2020-04-27

6.  Poor Performance Status Predicts Mortality After Living Donor Liver Transplantation.

Authors:  Narendra S Choudhary; Amey Sonavane; Neeraj Saraf; Sanjiv Saigal; Amit Rastogi; Prashant Bhangui; Srinivasan Thiagrajan; Sanjay K Yadav; Sujeet Saha; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2019-07-05

7.  Frailty and Outcomes After Liver Transplantation.

Authors:  Elliot B Tapper
Journal:  Curr Transplant Rep       Date:  2019-01-14

Review 8.  Sarcopenia and frailty in decompensated cirrhosis.

Authors:  Puneeta Tandon; Aldo J Montano-Loza; Jennifer C Lai; Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2021-07       Impact factor: 30.083

Review 9.  Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability.

Authors:  Felicity R Williams; Don Milliken; Jennifer C Lai; Matthew J Armstrong
Journal:  Hepatol Commun       Date:  2021-02-26

10.  Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jennifer C Lai; Puneeta Tandon; William Bernal; Elliot B Tapper; Udeme Ekong; Srinivasan Dasarathy; Elizabeth J Carey
Journal:  Hepatology       Date:  2021-09       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.